医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Research and Markets: Epidemiology: Inflammatory Bowel Disease – Early diagnosis and improved survival lead to increased patient populations

2012年09月26日 AM02:17
このエントリーをはてなブックマークに追加


 

DUBLIN

Research and Markets (http://www.researchandmarkets.com/research/kmdx39/epidemiology) has announced the addition of the “Epidemiology: Inflammatory Bowel Disease – Early diagnosis and improved survival lead to increased patient populations” report to their offering.

Inflammatory bowel diseases (IBDs) are mainly composed of three chronic diseases; Crohn’s disease, ulcerative colitis, and indeterminate colitis. Although the etiology of inflammatory bowel disease is largely unknown, the incidence of IBD has substantially increased in the past decade.

Gain insight into market potential, including a robust 10-year epidemiology forecast of Crohn’s disease and ulcerative colitis prevalent cases.Gain insights into the current and future prevalent trends of Crohn’s disease and ulcerative colitis in the next 10 years.Understand the key epidemiologic risk factors associated with inflammatory bowel diseases.Since the 1950s, the overall incidence of IBD has gradually increased, although the increase in the incidence of ulcerative colitis (UC) precedes the increase in Crohn’s disease (CD) by approximately 15-20 years.

Across the seven major markets, Datamonitor estimates that in 2011 there were approximately 913,000 and 1.7 million prevalent cases of Crohn’s disease and ulcerative colitis, respectively.Between 2011 and 2021, Datamonitor estimates that prevalent cases of both Crohn’s disease and ulcerative colitis will increase.How will the IBD patient population change over the next decade in the seven major markets?What are the estimated prevalent cases of Crohn’s disease and ulcerative colitis in the seven major markets?

Key Topics Covered:

– OVERVIEW

– EXECUTIVE SUMMARY

– DISEASE DEFINITION AND DIAGNOSIS CRITERIA

– GLOBAL VARIATION AND HISTORICAL TRENDS

– RISK FACTORS

– EPIDEMIOLOGIC FORECASTING OF INFLAMMATORY BOWEL DISEASE

– EPIDEMIOLOGIC RESULTS

– DISCUSSION

– BIBLIOGRAPHY

– TABLES

FIGURES

Companies Mentioned

– Bull

– Hutchison 3G UK Limited

– Metro AG

– Schindler Holding Ltd.

For more information visit http://www.researchandmarkets.com/research/kmdx39/epidemiology

CONTACT

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 三井化学开发全球首款灵活的高强度柔性无纺布AIRYFA™
  • APR应用制药研究公司参加第9届ChinaBio®合作论坛:依托瑞士创新产品和科学技术深耕中国市场
  • Dompé用于治疗中度或重度神经营养性角膜炎成人患者的Oxervate®(Cenegermin滴眼液)获得欧盟CHMP肯定意见
  • SCIEX Sponsored Award Recognizes Notable Contributions to Electrodriven Separations
  • LMDのV-Sensorがインドでバイタルサインを測定